197 related articles for article (PubMed ID: 30811545)
1. Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses.
Sergeys J; Etienne I; Van Hove I; Lefevere E; Stalmans I; Feyen JHM; Moons L; Van Bergen T
Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):807-822. PubMed ID: 30811545
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy.
Van Bergen T; Hu TT; Etienne I; Reyns GE; Moons L; Feyen JHM
Exp Eye Res; 2017 Dec; 165():136-150. PubMed ID: 28965804
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
[TBL] [Abstract][Full Text] [Related]
4. INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study.
Andrade GC; Dias JR; Maia A; Farah ME; Meyer CH; Rodrigues EB
Retina; 2016 Sep; 36(9):1640-5. PubMed ID: 26991646
[TBL] [Abstract][Full Text] [Related]
5. Aflibercept ameliorates retinal pericyte loss and restores perfusion in streptozotocin-induced diabetic mice.
Seo EJ; Choi JA; Koh JY; Yoon YH
BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33077473
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Retinal Structure and Visual Function Assessments in Mouse Diabetes Models.
Sheskey SR; Antonetti DA; Rentería RC; Lin CM
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):20. PubMed ID: 34410299
[TBL] [Abstract][Full Text] [Related]
7. Microperimetric assessment of retinal sensitivity in eyes with diabetic macular edema from a phase 2 study of intravitreal aflibercept.
Gonzalez VH; Boyer DS; Schmidt-Erfurth U; Heier JS; Gordon C; Benz MS; Marcus DM; Sabates NR; Vitti R; Kazmi H; Berliner AJ; Soo Y; Zhu X; Moini H; Zeitz O; Sandbrink R; Do DV
Retina; 2015 Apr; 35(4):687-94. PubMed ID: 25621943
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of Retinal Function in Streptozotocin-induced Diabetic Rats by Using the Electroretinography and Immunohistochemistry Methods].
Hiramatsu N; Deguchi S; Yoshioka C; Otake H; Yamamoto N; Nagai N
Yakugaku Zasshi; 2017; 137(9):1169-1175. PubMed ID: 28867704
[TBL] [Abstract][Full Text] [Related]
9. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
[TBL] [Abstract][Full Text] [Related]
10. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
[TBL] [Abstract][Full Text] [Related]
11. Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy.
Tomita Y; Lee D; Miwa Y; Jiang X; Ohta M; Tsubota K; Kurihara T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872333
[TBL] [Abstract][Full Text] [Related]
12. IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice.
Lennikov A; Hiraoka M; Abe A; Ohno S; Fujikawa T; Itai A; Ohguro H
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6365-73. PubMed ID: 25205865
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
14. Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.
Prager SG; Lammer J; Mitsch C; Hafner J; Pemp B; Scholda C; Kundi M; Schmidt-Erfurth U; Kriechbaum K
Acta Ophthalmol; 2018 Mar; 96(2):e195-e200. PubMed ID: 29063703
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice.
Yang XF; Huang YX; Lan M; Zhang TR; Zhou J
Chin Med J (Engl); 2018 Jan; 131(1):75-81. PubMed ID: 29271384
[TBL] [Abstract][Full Text] [Related]
16. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
17. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
[TBL] [Abstract][Full Text] [Related]
18. Ziv-aflibercept in macular disease.
Mansour AM; Al-Ghadban SI; Yunis MH; El-Sabban ME
Br J Ophthalmol; 2015 Aug; 99(8):1055-9. PubMed ID: 25677668
[TBL] [Abstract][Full Text] [Related]
19. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes.
Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H
Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207
[TBL] [Abstract][Full Text] [Related]
20. Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T.
Cai S; Bressler NM
Curr Opin Ophthalmol; 2017 Nov; 28(6):636-643. PubMed ID: 28837425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
